We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+4.01%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$6.7B
AUM Growth
+$144M
Cap. Flow
+$80.4M
Cap. Flow %
1.2%
Top 10 Hldgs %
21%
Holding
1,675
New
169
Increased
710
Reduced
579
Closed
127

Sector Composition

Rank Sector Weight
1 Technology 21.11%
2 Financials 10.66%
3 Industrials 8.26%
4 Consumer Discretionary 7.5%
5 Healthcare 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGEN icon
1426
Repligen
RGEN
$9.21B
$216K ﹤0.01%
+1,500
New +$215K
HYS icon
1427
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.77B
$216K ﹤0.01%
2,303
+145
+7% +$13.7K
CII icon
1428
BlackRock Enhanced Captial and Income Fund
CII
$1.02B
$215K ﹤0.01%
+10,700
New +$213K
RNR icon
1429
RenaissanceRe
RNR
$13.2B
$215K ﹤0.01%
864
+16
+2% +$4.3K
FDS icon
1430
Factset
FDS
$10.1B
$215K ﹤0.01%
+447
New +$212K
KNO
1431
AXS Knowledge Leaders ETF
KNO
$45.1M
$215K ﹤0.01%
4,961
-1,600
-24% -$72.9K
UTL icon
1432
Unitil
UTL
$966M
$213K ﹤0.01%
3,925
EGBN icon
1433
Eagle Bancorp
EGBN
$843M
$212K ﹤0.01%
+8,142
New +$219K
EVLV icon
1434
Evolv Technologies
EVLV
$1.05B
$211K ﹤0.01%
53,412
-1,000
-2% -$3.51K
VLTO icon
1435
Veralto
VLTO
$23.7B
$210K ﹤0.01%
2,062
-3,357
-62% -$358K
MSCI icon
1436
MSCI
MSCI
$40.9B
$209K ﹤0.01%
348
-7
-2% -$4.2K
VIOO icon
1437
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.3B
$209K ﹤0.01%
+1,968
New +$218K
NTLA icon
1438
Intellia Therapeutics
NTLA
$1.68B
$209K ﹤0.01%
+17,885
New +$279K
IUSB icon
1439
iShares Core Universal USD Bond ETF
IUSB
$43.1B
$208K ﹤0.01%
+4,608
New +$212K
FNY icon
1440
First Trust Mid Cap Growth AlphaDEX Fund
FNY
$600M
$208K ﹤0.01%
+2,602
New +$216K
SMG icon
1441
ScottsMiracle-Gro
SMG
$3.63B
$208K ﹤0.01%
3,134
+514
+20% +$40.6K
LUMN icon
1442
Lumen
LUMN
$6.85B
$207K ﹤0.01%
39,037
+3,109
+9% +$21.5K
RWL icon
1443
Invesco S&P 500 Revenue ETF
RWL
$9.95B
$207K ﹤0.01%
+2,113
New +$212K
FLIN icon
1444
Franklin FTSE India ETF
FLIN
$2.68B
$207K ﹤0.01%
5,456
-5,465
-50% -$216K
NXG
1445
NXG NextGen Infrastructure Income Fund
NXG
$344M
$206K ﹤0.01%
4,500
-343
-7% -$15.7K
HYZD icon
1446
WisdomTree Trust WisdomTree Interest Rate Hedged High Yield Bond Fund
HYZD
$260M
$206K ﹤0.01%
9,262
-265
-3% -$5.92K
HEI icon
1447
HEICO Corp
HEI
$50.9B
$206K ﹤0.01%
866
-336
-28% -$87K
SPOT icon
1448
Spotify
SPOT
$105B
$205K ﹤0.01%
459
-85
-16% -$36.4K
DRLL icon
1449
Strive US Energy ETF
DRLL
$298M
$205K ﹤0.01%
+7,526
New +$218K
PRF icon
1450
Invesco FTSE RAFI US 1000 ETF
PRF
$10B
$205K ﹤0.01%
+5,081
New +$210K

Similar funds

Oppenheimer & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Oppenheimer & Co held 1,675 positions worth $6.7B, up 2.2% from $6.56B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Oppenheimer & Co's Q4 2024 filing shows 169 new, 710 increased, 579 reduced and 127 closed positions. Its largest new stake was FT Vest US Equity Deep Buffer ETF November: 493,441 shares worth $21.2M. The largest sale was FT Vest US Equity Deep Buffer ETF March, an estimated $21.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.

  • Oppenheimer & Co's largest Q4 2024 buy was FT Vest US Equity Deep Buffer ETF November: 493,441 shares worth $21.2M.
  • Oppenheimer & Co added most to iShares Russell Mid-Cap Growth ETF in Q4 2024, an estimated $12.8M increase.
  • Oppenheimer & Co's biggest Q4 2024 reduction was FT Vest US Equity Deep Buffer ETF March, cutting an estimated $21.8M.
  • Oppenheimer & Co fully exited Innovative Industrial Properties in Q4 2024, selling an estimated $6.32M.
  • Oppenheimer & Co's ten largest holdings make up 21% of its $6.7B portfolio in Q4 2024.
  • Oppenheimer & Co opened 169 new positions and closed 127 in Q4 2024.
  • Oppenheimer & Co's portfolio value rose 2.2% quarter-over-quarter to $6.7B.

Based on Oppenheimer & Co's 13F filing for Q4 2024, filed 5 Feb 2025.